Bioabsorbable Stents Market By Absorption Rate (Slow Absorption Stents, High Absorption Stents), By Drugs (Paclitaxel, Limus Based Drugs), By Applications (Coronary Artery Disease, Peripheral Artery Disease), By End Users (Hospitals, Cardiac Centers), By Materials (Polymeric Stents, Metallic Stents) , Industry Size, Growth, Share And Forecast To 2022
Key Findings
The global bioabsorbable stents market is expected to grow at the CAGR of 44.7 % during 2016-2022 and is expected to reach around $2800 million till 2022.Stent is a device commonly used for the treatment of blocked arteries. The bioabsorbable stents are tiny &expandable mesh tubes that holds weak and open arteries, helping out to treatseveral peripheral and coronary arteries diseases.Bioabsorbable stents are defined as fully biodegradable stents that completely get absorbs in human body.The percutaneous coronary intervention, majorly known as angioplasty, is the most effective treatment for peripheral andcoronary artery diseases. In this type of procedure, Bioabsorbable stents are placed in arteries to keep it open. There has been rising number of angioplasty procedures due to rising cardiovascular diseases, driving the global bioabsorbable stents market. Slow adoption rate ofbioabsorbable stents in heart related diseases is one of the majorproblembeing faced by the global marketand it also acts as a restraint in the growth of the market.
Market Segment Insight
Theglobal bioabsorbable stents marketis majorly segmented on the basis ofabsorption rate, drugs, applications, end users, materials and regional outlook.Onthe basis of absorption rate segment, market is being divided into slow absorption stents and high absorption stents. Slow absorption rate stents hasregistered maximum market share in 2015 owing to the longer effect ofmedicines and drugs which is being released within the artery.It insures efficient healing.On the basis of drugs, market is segmented into paclitaxel and limus based drugs.
In application segment,the market is divided into coronary artery disease and peripheral artery disease. The coronary artery diseases has been increasing rapidly due to growing prevalence of lifestyle oriented diseases such as obesity, heart attacks, strokes, etc., rising geriatric population base is also pushing coronary artery diseases upward. Due to rising coronary artery diseases application, bioabsorbable stents is witnessing huge demand.
In end users segment, market is divided into hospitals and cardiac centers. Hospitals are the major end users of bioabsorbable stents. Rising healthcare standard and infrastructure in hospitals and rising heart diseasespatient’s walk-ins in hospitals are the major factor boosting end user segment of global bioabsorbable stents market.In materials segment, market is divided into polymeric stents and metallic stents.The polymeric bioabsorbable stents are majorly used in cardiovascular devices. Polymers which are used in bioabsorbable stents are polycaprolactone, poly-l-lactic acid, poly, polyglycolic acid (PGA), (d, l-lactide/glycolide) copolymer (PDLA).
Use of bioabsorbable polymer in coatingreduces thrombotic events anddecreases the need for extending dual anti-platelet therapy.Magnesiumand iron are the most commonly used metals to make metallic bioabsorbable stents.
The factors determining the biocompatibility of these alloys are their solubility and degradation properties.Magnesium bioabsorbable stents are widely used metallic alloy stents in arteries related diseases, as magnesium is one of the essential element of human body. On the basis of regional outlook,market is divided into North America, Europe, Asia Pacific and Rest of the World.
Regional Insight
Regionally,market is divided into North America, Europe, Asia Pacific and Rest of the World.North America is having the maximum market share of global bioabsorbable stents market owing torise in awareness about thebioabsorbable stents in the treatment of coronary ailments, rising prevalence of obesity, heart attacks and other cardiac diseases. Dominance of major players in this region is also fueling the global bioabsorbable stents market. United States represents the largest market for bioabsorbable stents in North American region, followed by Canada. In European region, Italy, Germany and U.K are having largest market share of global bioabsorbable stents market. Rising awareness regarding obesity related health issues and increasing health care expenditures are enhancing theglobal bioabsorbable stents market. Asia Pacific region has been expected to exhibit high growth rate in the forecasted year owingto increase in public awareness related to variousperipheral and coronary artery diseases in the region. India, China and Japan are expected to be the fastest growing bioabsorbable stents markets in Asia Pacific. Rest of the world is also growing but not at a faster rate. Slow adoption of bioabsorbable stents, and lack of knowledge regarding artery diseases are some factors restraining the growth in this region.
Competitive Insights
Key market players areKyoto medical planning co., Ltd., Elixir medical corporation, Boston scientific corp.,Xenogenics corporation (a subsidiary of multicell technologies, Inc.), Tepha, Inc., Reva medical Inc., Meril life sciences, Medtronic Inc., etc. Mergers, acquisitions, product launch are the key strategies adopted by these players to sustain in the market.
CHAP 1.METHODOLOGY & SCOPE13
1.1.RESEARCH METHODOLOGY13
1.2.RESEARCH SCOPE & ASSUMPTIONS13
1.3.LIST OF DATA SOURCES13
CHAP 2.EXECUTIVE SUMMARY14
2.1.GLOBAL BIOABSORBABLE STENTS MARKET SUMMARY & KEY BUYING CRITERIA14
2.2.GLOBAL BIOABSORBABLE STENTS MARKET OUTLOOK14
2.3.MARKET SEGMENTATION ANALYSIS14
2.4.MARKET SIZE AND GROWTH PROSPECTS 2012-202214
2.5.GLOBAL BIOABSORBABLE STENTS MARKET VALUE CHAIN ANALYSIS14
2.6.VENDOR LANDSCAPE14
CHAP 3.GLOBAL BIOABSORBABLE STENTS MARKET15
3.1.MARKET DRIVER ANALYSIS15
3.1.1.RAPIDLY GROWING GERIATRIC POPULATION15
3.1.2.GROWING RISK OF CORONARY ARTERY DISEASES AND PERIPHERAL ARTERY DISEASES IN THE ELDERLY POPULATION15
3.1.3.STRONG PRODUCT PIPELINES15
3.2.MARKET RESTRAINT ANALYSIS15
3.2.1.HIGH COST OF DEVICES15
3.2.2.SLOW ADOPTION RATE15
3.3.KEY OPPORTUNITIES15
3.3.1.EMERGING MARKETS TO OFFER HIGH GROWTH OPPORTUNITIES FOR MARKET PLAYERS15
3.3.2.TARGET HIGH RISK PATIENTS15
3.4.CHALLENGES15
CHAP 4.INDUSTRY ANALYSIS16
4.1.GLOBAL BIOABSORBABLE STENTS MARKET– PORTER’S FIVE FORCE MODEL16
4.2.GLOBAL BIOABSORBABLE STENTS MARKET– PESTEL ANALYSIS16
4.3.GLOBAL BIOABSORBABLE STENTS MARKET– GAP ANALYSIS16
CHAP 5.GLOBAL BIOABSORBABLE STENTS MARKET BY ABSORPTION RATE 2012-2022 ($ MILLION)17
5.1.GLOBAL BIOABSORBABLE STENTS MARKET BY SLOW ABSORPTION STENTS 2012-2022 ($ MILLION)17
5.2.GLOBAL BIOABSORBABLE STENTS MARKET BY HIGH ABSORPTION STENTS 2012-2022 ($ MILLION)17
CHAP 6.GLOBAL BIOABSORBABLE STENTS MARKET BY DRUGS 2012-2022 ($ MILLION)18
6.1.GLOBAL BIOABSORBABLE STENTS MARKET BY PACLITAXEL 2012-2022 ($ MILLION)18
6.2.GLOBAL BIOABSORBABLE STENTS MARKET BY LIMUS BASED DRUGS 2012-2022 ($ MILLION)18
CHAP 7.GLOBAL BIOABSORBABLE STENTS MARKET BY APPLICATIONS 2012-2022 ($ MILLION)19
7.1.GLOBAL BIOABSORBABLE STENTS MARKET BY CORONARY ARTERY DISEASE 2012-2022 ($ MILLION)19
7.2.GLOBAL BIOABSORBABLE STENTS MARKET BY PERIPHERAL ARTERY DISEASE 2012-2022 ($ MILLION)19
CHAP 8.GLOBAL BIOABSORBABLE STENTS MARKET BY END USERS 2012-2022 ($ MILLION)20
8.1.GLOBAL BIOABSORBABLE STENTS MARKET BY HOSPITALS 2012-2022 ($ MILLION)20
8.2.GLOBAL BIOABSORBABLE STENTS MARKET BY CARDIAC CENTERS 2012-2022 ($ MILLION)20
CHAP 9.GLOBAL BIOABSORBABLE STENTS MARKET BY MATERIALS 2012-2022 ($ MILLION)21
9.1.GLOBAL BIOABSORBABLE STENTS MARKET BY POLYMERIC STENTS 2012-2022 ($ MILLION)21
9.2.GLOBAL BIOABSORBABLE STENTS MARKET BY METALLIC STENTS 2012-2022 ($ MILLION)21
CHAP 10.GLOBAL ABLATION TECHNOLOGIES MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION)22
10.1.GLOBAL BIOABSORBABLE STENTS MARKET BY REGION 2012-2022 ($ MILLION)22
10.2.NORTH AMERICA22
10.2.1.NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)22
10.2.2.NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)22
10.2.3.NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION)22
10.2.3.1.U.S.22
10.2.3.1.1.U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)22
10.2.3.1.2.U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)22
10.2.3.2.CANADA22
10.2.3.2.1.CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)22
10.2.3.2.2.CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)22
10.2.3.3.MEXICO22
10.2.3.3.1.MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)22
10.2.3.3.2.MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)22
10.3.EUROPE23
10.3.1.EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)23
10.3.2.EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)23
10.3.3.EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION)23
10.3.3.1.GERMANY23
10.3.3.1.1.GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)23
10.3.3.1.2.GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)23
10.3.3.2.UK23
10.3.3.2.1.UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)23
10.3.3.2.2.UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)23
10.3.3.3.FRANCE23
10.3.3.3.1.FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)23
10.3.3.3.2.FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)23
10.3.3.4.SPAIN23
10.3.3.4.1.SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)23
10.3.3.4.2.SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)23
10.3.3.5.ITALY23
10.3.3.5.1.ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)24
10.3.3.5.2.ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)24
10.3.3.6.REST OF EUROPE24
10.3.3.6.1.REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022($MILLION)24
10.3.3.6.2.REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION)24
10.4.ASIA PACIFIC24
10.4.1.ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)24
10.4.2.ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)24
10.4.3.ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION)24
10.4.3.1.CHINA24
10.4.3.1.1.CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)24
10.4.3.1.2.CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)24
10.4.3.2.INDIA24
10.4.3.2.1.INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)24
10.4.3.2.2.INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)24
10.4.3.3.JAPAN24
10.4.3.3.1.JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)24
10.4.3.3.2.JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION)24
10.4.3.4.SOUTH KOREA24
10.4.3.4.1.SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)25
10.4.3.4.2.SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION)25
10.4.3.5.REST OF APAC25
10.4.3.5.1.REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)25
10.4.3.5.2.REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)25
10.5.REST OF THE WORLD25
10.5.1.REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)25
10.5.2.REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)25
10.5.3.REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION)25
10.5.3.1.LATIN AMERICA25
10.5.3.1.1.LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)25
10.5.3.1.2.LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)25
10.5.3.2.MIDDLE EAST AND AFRICA25
10.5.3.2.1.MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION)25
10.5.3.2.2.MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION)25
CHAP 11.COMPETITIVE LANDSCAPE26
11.1.ABBOTT LABORATORIES27
11.1.2.SCOT ANALYSIS27
11.1.3.PRODUCT BENCHMARKING27
11.1.4.STRATEGIC INITIATIVES27
11.2.AMARANTH MEDICAL INC.27
11.2.2.SCOT ANALYSIS27
11.2.3.PRODUCT BENCHMARKING27
11.2.4.STRATEGIC INITIATIVES27
11.3.ARTERIAL REMODELING TECHNOLOGIES27
11.3.2.SCOT ANALYSIS27
11.3.3.PRODUCT BENCHMARKING27
11.3.4.STRATEGIC INITIATIVES27
11.4.ARTERIUS LIMITED27
11.4.2.PRODUCT BENCHMARKING27
11.4.3.STRATEGIC INITIATIVES27
11.5.BIOTRONIK27
11.5.2.SCOT ANALYSIS27
11.5.3.PRODUCT BENCHMARKING27
11.5.4.STRATEGIC INITIATIVES27
11.6.BOSTON SCIENTIFIC CORP.27
11.6.2.SCOT ANALYSIS27
11.6.3.PRODUCT BENCHMARKING28
11.6.4.STRATEGIC INITIATIVES28
11.7.ELIXIR MEDICAL CORPORATION28
11.7.2.SCOT ANALYSIS28
11.7.3.PRODUCT BENCHMARKING28
11.7.4.STRATEGIC INITIATIVES28
11.8.JOHNSON & JOHNSON28
11.8.2.SCOT ANALYSIS28
11.8.3.PRODUCT BENCHMARKING28
11.8.4.STRATEGIC INITIATIVES28
11.9.KYOTO MEDICAL PLANNING CO. LTD.28
11.9.2.SCOT ANALYSIS28
11.9.3.PRODUCT BENCHMARKING28
11.9.4.STRATEGIC INITIATIVES28
11.10.MEDTRONIC INC.28
11.10.2.SCOT ANALYSIS28
11.10.3.PRODUCT BENCHMARKING28
11.10.4.STRATEGIC INITIATIVES28
11.11.MERIL LIFE SCIENCES28
11.11.2.SCOT ANALYSIS28
11.11.3.PRODUCT BENCHMARKING28
11.11.4.STRATEGIC INITIATIVES28
11.12.REVA MEDICAL INC.29
11.12.2.SCOT ANALYSIS29
11.12.3.PRODUCT BENCHMARKING29
11.12.4.STRATEGIC INITIATIVES29
11.13.SMT (PART OF SAHAJANAND GROUP OF COMPANIES)29
11.13.2.SCOT ANALYSIS29
11.13.3.PRODUCT BENCHMARKING29
11.13.4.STRATEGIC INITIATIVES29
11.14.TEPHA INC.29
11.14.2.SCOT ANALYSIS29
11.14.3.PRODUCT BENCHMARKING29
11.14.4.STRATEGIC INITIATIVES29
11.15.XENOGENICS CORPORATION (A SUBSIDIARY OF MULTICELL TECHNOLOGIES INC.)29
11.15.2.SCOT ANALYSIS29
11.15.3.PRODUCT BENCHMARKING29
11.15.4.STRATEGIC INITIATIVES29
TABLE 1 GLOBAL BIOABSORBABLE STENTS MARKET BY ABSORPTION RATE 2012-2022 ($ MILLION) 29
TABLE 2 GLOBAL BIOABSORBABLE STENTS MARKET BY SLOW ABSORPTION STENTS 2012-2022 ($ MILLION) 29
TABLE 3 GLOBAL BIOABSORBABLE STENTS MARKET BY HIGH ABSORPTION STENTS 2012-2022 ($ MILLION) 29
TABLE 4 GLOBAL BIOABSORBABLE STENTS MARKET BY DRUGS 2012-2022 ($ MILLION) 30
TABLE 5 GLOBAL BIOABSORBABLE STENTS MARKET BY PACLITAXEL 2012-2022 ($ MILLION) 30
TABLE 6 GLOBAL BIOABSORBABLE STENTS MARKET BY LIMUS BASED DRUGS 2012-2022 ($ MILLION) 30
TABLE 7 GLOBAL BIOABSORBABLE STENTS MARKET BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 8 GLOBAL BIOABSORBABLE STENTS MARKET BY CORONARY ARTERY DISEASE 2012-2022 ($ MILLION) 30
TABLE 9 GLOBAL BIOABSORBABLE STENTS MARKET BY PERIPHERAL ARTERY DISEASE 2012-2022 ($ MILLION) 30
TABLE 10 GLOBAL BIOABSORBABLE STENTS MARKET BY END USERS 2012-2022 ($ MILLION) 30
TABLE 11 GLOBAL BIOABSORBABLE STENTS MARKET BY HOSPITALS 2012-2022 ($ MILLION) 30
TABLE 12 GLOBAL BIOABSORBABLE STENTS MARKET BY CARDIAC CENTERS 2012-2022 ($ MILLION) 30
TABLE 13 GLOBAL BIOABSORBABLE STENTS MARKET BY MATERIALS 2012-2022 ($ MILLION) 30
TABLE 14 GLOBAL BIOABSORBABLE STENTS MARKET BY POLYMERIC STENTS 2012-2022 ($ MILLION) 30
TABLE 15 GLOBAL BIOABSORBABLE STENTS MARKET BY METALLIC STENTS 2012-2022 ($ MILLION) 30
TABLE 16 GLOBAL ABLATION TECHNOLOGIES MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 30
TABLE 17 GLOBAL BIOABSORBABLE STENTS MARKET BY REGION 2012-2022 ($ MILLION) 30
TABLE 18 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 19 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 20 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 30
TABLE 21 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 22 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 23 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 24 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 25 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 26 MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 27 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 28 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 29 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 31
TABLE 30 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 31 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 32 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 33 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 34 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 35 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 36 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 37 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 38 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 39 ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 40 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 32
TABLE 41 REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 42 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 43 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 44 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 32
TABLE 45 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 46 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 47 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 48 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 49 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 50 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 51 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 52 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 53 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 54 REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 55 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 56 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 57 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 33
TABLE 58 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 59 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 60 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 61 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
FIGURE 1 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 2 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
FIGURE 9 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 10 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 34
FIGURE 11 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 12 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 13 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 14 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 15 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 16 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 17 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 18 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 19 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)